Translate
About
Radiopharm Theranostics Ltd (AU:RAD) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 23 2026
Radiopharm Theranostics Reports Business Update
Apr 20 2026
Radiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial for 177Lu-RAD202 in HER2+ Solid Tumors at American Association for Cancer Research 2026
Apr 16 2026
Radiopharm Theranostics Completes Enrollment in U.S. Phase 2b Imaging Trial of RAD 101 for Diagnosis of Brain Metastases
Apr 16 2026
RAD Completes Enrollment in Phase 2b Trial of RAD 101
Apr 8 2026
Radiopharm Theranostics Advances to Cohort 3 in 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial
Financials
Revenue
A$16.28 M
Market Cap
A$49.66 M
EPS
-0.02